Expression of IFN-gamma, IL-4, and TGF-beta in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Multiple Sclerosis

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 9345450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transforming growth factor-beta 1 suppresses autoantigen-induced expression of pro-inflammatory cytokines but not of interleukin-10 in multiple sclerosis and myasthenia gravis.

  1995cited by this paper
• Increased mRNA Expression of IL‐10 in Mononuclear Cells in Multiple Sclerosis and Optic Neuritis

  1995cited by this paper
• Cytokine mRNA profiles in mononuclear cells in acute aseptic meningoencephalitis

  1995cited by this paper
• Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

  1994cited by this paper
• Lymphocyte responses and cytokines.

  1994cited by this paper
• Spontaneous expression of IL‐4 mRNA in lymphocytes from children with atopic dermatitis

  1994cited by this paper
• The Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis lesion

  1994cited by this paper
• Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis

  1994cited by this paper
• Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.

  1994cited by this paper
• Increased transforming growth factor‐β, interleukin‐4, and interferon‐γ in multiple sclerosis

  1994cited by this paper
• Organ‐specific autoantigens induce interferon‐γ and interleukin‐4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis

  1994cited by this paper
• Organ‐specific autoantigens induce transforming growth factor‐β mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis

  1994cited by this paper
• Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis

  1994cited by this paper
• Human leukocyte antigen studies in multiple sclerosis

  1994cited by this paper
• Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor.

  1993cited by this paper
• Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis.

  1993cited by this paper
• The pathophysiology of tumor necrosis factors.

  1992cited by this paper
• Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis.

  1992cited by this paper
• Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry

  1992cited by this paper
• Myelin antigen reactive T cells in cerebrovascular diseases

  1992cited by this paper
• T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis.

  1991cited by this paper
• Molecular cloning of rat interleukin 4 cDNA and analysis of the cytokine repertoire of subsets of CD4+ T cells

  1991cited by this paper
• Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma.

  1990cited by this paper
• The cell biology of transforming growth factor beta.

  1990cited by this paper
• IL-4 inhibits superoxide production by human mononuclear phagocytes.

  1990cited by this paper
• IL-4 down-regulates IL-1 and TNF gene expression in human monocytes.

  1989cited by this paper
• MRI in the diagnosis of MS

  1988cited by this paper
• Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

  1988cited by this paper
• HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology.

  1987cited by this paper
• Treatment of multiple sclerosis with gamma interferon

  1987cited by this paper
• Allogenotypes defined by short DQ alpha and DQ beta cDNA probes correlate with and define splits of HLA-DQ serological specificities.

  1987cited by this paper
• The role of lymphotoxin in T-cell-mediated cytotoxicity.

  1987cited by this paper
• Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities.

  1986cited by this paper
• Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells

  1985cited by this paper
• Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labeling, and avidin-biotin amplification.

  1984cited by this paper
• Rating neurologic impairment in multiple sclerosis

  1983cited by this paper
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

  1983cited by this paper
• Structure of the human immune interferon gene

  1982cited by this paper
• Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species.

  1972cited by this paper

• Aging-dependent change in Th17 and cytokine response in multiple sclerosis

  2025cites this paper
• Increased level of GATA3-AS1 long non-coding RNA is correlated with the upregulation of GATA3 and IL-4 genes in multiple sclerosis patients

  2024cites this paper
• Relation between microRNA‐155 and inflammatory mediators in multiple sclerosis

  2023cites this paper
• Interferon-γ potentiates GABAA receptor-mediated inhibitory currents in rat hippocampal CA1 pyramidal neurons.

  2019cites this paper
• TGF-β Family Signaling in Neural and Neuronal Differentiation, Development, and Function.

  2017cites this paper
• Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status and function of the cells?

  2017cites this paper
• The Neuroprotective Functions of Transforming Growth Factor Beta Proteins

  2012cites this paper
• CNS endothelium expression of ADAM-17 and its role in multiple sclerosis pathogenesis

  2009cites this paper
• Interleukin‐4 as a Neuromodulatory Cytokine

  2009cites this paper
• The genetics of clinical outcome in multiple sclerosis.

  2008cites this paper
• Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis

  2005cites this paper
• Methylprednisolone treatment, immune activation, and intrathecal inflammation in multiple sclerosis.

  2004cites this paper
• IL-4 in vitro production is upregulated in Alzheimer's disease patients treated with acetylcholinesterase inhibitors.

  2004cites this paper
• Multiple sclerosis complexity in selected populations: the challenge of Sardinia, insular Italy 1

  2002cites this paper
• Interferon beta-1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis.

  2002cites this paper
• Sequence variation in the transforming growth factor-beta1 (TGFB1) gene and multiple sclerosis susceptibility.

  2001cites this paper
• From Basic Immunology to Immune-Mediated Demyelination

  1999influential citation
• Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines.

  1999cites this paper
• Cytokine mRNA profile of myelin basic protein reactive T-cell clones in patients with multiple sclerosis.

  1998cites this paper
• Pathogenesis of immune-mediated demyelination in the CNS.

  1997cites this paper